NCT02887495View on ClinicalTrials.gov

The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

February 2, 2022

Study Completion Date

February 2, 2022

Conditions
Scleroderma
Trial Locations (1)

20037

Victoria K Shanmugam, Washington D.C.

All Listed Sponsors
lead

George Washington University

OTHER

NCT02887495 - The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma) | Biotech Hunter | Biotech Hunter